Clinical Trial Update: Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating human umbilical cord mesenchymal stem cells for systemic lupus erythematosus. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shenzhen Beike Bio-Technology Co., Ltd. | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 1, Phase 2 | Status: RECRUITING